A lack of responsiveness to E2 in ovarian cancers has been demonstrated in SKOV3 to be due to a mutation in estrogen receptor-α [34], and thus is a plausible explanation for the hypersialylated phenotype despite an estrogenic microenvironment. Here, ESR1 is linked to ovarian carcinoma.